首页> 外文期刊>Urology >Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate.
【24h】

Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate.

机译:逼尿肌过度活动对前列腺素钾-磷酸钾-锡选择性磷酸化后储存症状的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To investigate whether the presence of detrusor overactivity (DO) influences storage symptoms after photoselective laser vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH). METHODS: A total of 149 patients who underwent PVP were included in this retrospective study. All patients underwent a preoperative evaluation including multichannel video urodynamics. The efficacy of the PVP was assessed at 1, 3, 6, and 12 months postoperatively using the International Prostate Symptom Score (IPSS), uroflowmetry, postvoid residual urine volume, and 3-day frequency-volume charts (FVC). The patients were stratified into 2 groups (DO group vs non-DO group). RESULTS: The IPSS and FVC showed that the storage symptoms were reduced significantly after the PVP in both groups (P<.05). Starting from 6 months after the PVP, the DO group (n=39) showed a significantly greater reduction in the subtotal storage symptom score than the non-DO group (n=110). When the improvement of storage symptoms was defined as a reduction of >or=50% in the subtotal storage symptom scores, the percentage of patients with improvement in the storage symptoms at 1, 3, 6, and 12 months after the PVP was 13.9%, 25.9%, 47.8%, and 52.9% in the DO group, and 22.2%, 24.4%, 33.3%, and 33.3% in the non-DO group, respectively. CONCLUSIONS: Our results show that storage and voiding symptoms significantly improved after the PVP. In addition, we found that men with DO might show more improvement of storage symptoms, after the PVP, than men without DO.
机译:目的:研究前列腺良性前列腺增生(BPH)的光选择性激光汽化(PVP)后,逼尿肌过度活动(DO)的存在是否会影响存储症状。方法:本回顾性研究共纳入149名接受PVP的患者。所有患者均接受术前评估,包括多通道视频尿动力学检查。术后1、3、6和12个月使用国际前列腺症状评分(IPSS),尿流仪,术后无残余尿量和3天频度图(FVC)评估PVP的疗效。将患者分为2组(DO组与非DO组)。结果:IPSS和FVC显示两组患者PVP后的存储症状均明显减轻(P <.05)。从PVP后6个月开始,DO组(n = 39)显示的小计入库症状评分明显低于非DO组(n = 110)。当将贮藏症状的改善定义为小计贮藏症状分数降低≥50%时,PVP后1、3、6和12个月贮藏症状改善的患者百分比为13.9% DO组分别为25.9%,47.8%和52.9%,非DO组分别为22.2%,24.4%,33.3%和33.3%。结论:我们的结果表明,PVP后的储存和排尿症状明显改善。此外,我们发现,PVP后,有DO的男性比没有DO的男性可能显示出更多的存储症状改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号